Patient reported outcomes for cisplatin and radiation followed by carboplatin/paclitaxel versus carboplatin/paclitaxel for locally advanced endometrial carcinoma: An NRG oncology study.
第一作者:
Ursula A,Matulonis
第一单位:
Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: Ursula_Matulonis@dfci.harvard.edu.
作者:
主题词
卡铂(Carboplatin);化学疗法, 辅助(Chemotherapy, Adjuvant);顺铂(Cisplatin);无病生存(Disease-Free Survival);子宫内膜肿瘤(Endometrial Neoplasms);女(雌)性(Female);胃肠疾病(Gastrointestinal Diseases);人类(Humans);肿瘤分期(Neoplasm Staging);紫杉酚(Paclitaxel);周围神经系统疾病(Peripheral Nervous System Diseases);生活质量(Quality of Life)
DOI
10.1016/j.ygyno.2021.11.021
PMID
34903380
发布时间
2023-02-02
- 浏览2

Gynecologic oncology
428-436页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文